These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 379650)

  • 41. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease.
    Schluep M; Steck AJ
    Neurology; 1988 Dec; 38(12):1890-2. PubMed ID: 2461538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proceedings: Pharmacological properties of a cholinergic-receptor antiserum.
    Berti F; Clementi F; Conti-Tronconi B; Omini C
    Br J Pharmacol; 1974 Nov; 52(3):468P. PubMed ID: 4458882
    [No Abstract]   [Full Text] [Related]  

  • 43. Dense-core vesicles in motor nerve terminals. Monoaminergic innervation of slow non-twitch muscle fibers in the Atlantic hagfish (Myxine glutinosa, L.)?
    Korneliussen H
    Z Zellforsch Mikrosk Anat; 1973; 140(3):425-32. PubMed ID: 4737725
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparison of synaptic vesicles of neuromuscular and nerve electroplaque junctions in Torpedo marmorata].
    Brochier G; Israel M; Lesbats B
    C R Acad Sci III; 1991; 313(12):573-8. PubMed ID: 1773361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of paralysis in nerve-muscle preparations isolated from animals with hereditary motor endplate disease.
    Harris JB; Pollard SL
    Br J Pharmacol; 1985 Jan; 84(1):6-8. PubMed ID: 2983805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etomidate evokes synaptic vesicle exocytosis without increasing miniature endplate potentials frequency at the mice neuromuscular junction.
    Valadão PA; Naves LA; Gomez RS; Guatimosim C
    Neurochem Int; 2013 Nov; 63(6):576-82. PubMed ID: 24044896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical localization and immunoelectrophoresis of cholinergic synaptic vesicle protein constituents from the Torpedo.
    Ulmar G; Whittaker VP
    Brain Res; 1974 May; 71(1):155-9. PubMed ID: 4206918
    [No Abstract]   [Full Text] [Related]  

  • 49. Spontaneous elimination of nerve terminals from the endplates of developing skeletal myofibers.
    Riley DA
    Brain Res; 1977 Oct; 134(2):279-85. PubMed ID: 890492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the mechanism of acetylcholine release.
    Israël M; Dunant Y
    Prog Brain Res; 1979; 49():125-39. PubMed ID: 229512
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytoplasmic actin in postsynaptic structures at the neuromuscular junction.
    Hall ZW; Lubit BW; Schwartz JH
    J Cell Biol; 1981 Sep; 90(3):789-92. PubMed ID: 7026578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FM1-43 dye ultrastructural localization in and release from frog motor nerve terminals.
    Henkel AW; Lübke J; Betz WJ
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1918-23. PubMed ID: 8700859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consequences of blocking the nerve with a local anaesthetic on the evolution of multiinnervation at the regenerating neuromuscular junction of the rat.
    Benoit P; Changeux JP
    Brain Res; 1978 Jun; 149(1):89-96. PubMed ID: 656962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 55. [A reminder of the structure and function of the skeletal neuromuscular junction].
    Molgó J; Colasante C; Benoit E; Poulain B
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S55-60. PubMed ID: 19576486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immunopathology of acquired myasthenia gravis.
    Engel AG; Sahashi K; Fumagalli G
    Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between quantal secretion and vesicle loss at the frog neuromuscular junction.
    Hurlbut WP; Iezzi N; Fesce R; Ceccarelli B
    J Physiol; 1990 Jun; 425():501-26. PubMed ID: 2120425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evolution of an experimental distal motor axonopathy. Physiological studies of changes in neuromuscular transmission caused by cycloleucine, an inhibitor of methionine adenosyltransferase.
    Edwards JP; Lee CC; Duchen LW
    Brain; 1994 Oct; 117 ( Pt 5)():959-74. PubMed ID: 7953605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Staining of living presynaptic nerve terminals with selective fluorescent dyes.
    Yoshikami D; Okun LM
    Nature; 1984 Jul 5-11; 310(5972):53-6. PubMed ID: 6610832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Habitual exercise enhances neuromuscular transmission efficacy of rat soleus muscle in situ.
    Desaulniers P; Lavoie PA; Gardiner PF
    J Appl Physiol (1985); 2001 Mar; 90(3):1041-8. PubMed ID: 11181618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.